A phase I study on the combination of neoadjuvant radiotherapy plus pazopanib in patients with locally advanced soft tissue sarcoma of the extremities

Long-term responders and survivors on pazopanib for advanced soft tissue sarcomas: subanalysis of two European Organisation for Research and Treatment of Cancer (EORTC) clinical trials 62043 and 62072

(2014) B. Kasper et al.   ANNALS OF ONCOLOGY

Phase I Trial of Neoadjuvant Conformal Radiotherapy Plus Sorafenib for Patients with Locally Advanced Soft Tissue Sarcoma of the Extremity

(2014) Robert J. Canter et al.   ANNALS OF SURGICAL ONCOLOGY

A phase Ib/II translational study of sunitinib with neoadjuvant radiotherapy in soft-tissue sarcoma

(2014) J Lewin et al.   BRITISH JOURNAL OF CANCER

Relationships between pazopanib exposure and clinical safety and efficacy in patients with advanced renal cell carcinoma

(2014) A B Suttle et al.   BRITISH JOURNAL OF CANCER

Current clinical trials for advanced osteosarcoma and soft tissue sarcoma

(2014) Stefan Sleijfer et al.   CURRENT OPINION IN ONCOLOGY

Risk of liver toxicity with the angiogenesis inhibitor pazopanib in cancer patients

(2013) Samir Kapadia et al.   ACTA ONCOLOGICA

Phase 2 study of preoperative image-guided intensity-modulated radiation therapy to reduce wound and combined modality morbidities in lower extremity soft tissue sarcoma

(2013) Brian O'Sullivan et al.   CANCER

Risk Factors for Significant Wound Complications Following Wide Resection of Extremity Soft Tissue Sarcomas

(2013) Adam Schwartz et al.   CLINICAL ORTHOPAEDICS AND RELATED RESEARCH

Pazopanib, a new therapy for metastatic soft tissue sarcoma

(2013) Jaap Verweij et al.   EXPERT OPINION ON PHARMACOTHERAPY

Cytokine and angiogenic factors associated with efficacy and toxicity of pazopanib in advanced soft-tissue sarcoma: an EORTC-STBSG study

(2012) S Sleijfer et al.   BRITISH JOURNAL OF CANCER

Radiotherapy for Management of Extremity Soft Tissue Sarcomas: Why, When, and Where?

(2012) Rick L.M. Haas et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial

(2012) Winette TA van der Graaf et al.   LANCET

Radiographic and Histologic Response to Neoadjuvant Radiotherapy in Patients With Soft Tissue Sarcoma

(2010) Robert J. Canter et al.   ANNALS OF SURGICAL ONCOLOGY

Phase II Study of Neoadjuvant Bevacizumab and Radiotherapy for Resectable Soft Tissue Sarcomas

(2010) Sam S. Yoon et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis

(2009) John M.L. Ebos et al.   CANCER CELL

Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis

(2009) Marta Pàez-Ribes et al.   CANCER CELL

Pazopanib, a Multikinase Angiogenesis Inhibitor, in Patients With Relapsed or Refractory Advanced Soft Tissue Sarcoma: A Phase II Study From the European Organisation for Research and Treatment of Cancer–Soft Tissue and Bone Sarcoma Group (EORTC Study 62043)

(2009) Stefan Sleijfer et al.   JOURNAL OF CLINICAL ONCOLOGY

Effectiveness of Radiotherapy in Myxoid Sarcomas Is Associated With a Dense Vascular Pattern

(2008) Ronald S.A. de Vreeze et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS